Cipla launches diagnostic device, says it will provide results in minutes

Cippoint offers parameters to test for cardiac markers, diabetes, infectious diseases, fertility

Drugmaker Cipla said on Wednesday it has launched a diagnostic device to test for diabetes, infectious diseases, cardiac markers, thyroid function and other conditions.

Cippoint will allow healthcare professionals to get test results in 3 to 15 minutes, enabling a faster clinical decision-making process. The device has an automated system and is user-friendly and it can be used in remote areas or mobile vans, said the company.

Cipla did not disclose the device’s price and where it will be deployed: at doctors' clinics or for home-use by consumers.

Cippoint offers a wide range of parameters to test